The Surgical Robots Market size was valued at USD 10.7 billion in 2023 and is projected to grow from USD 12.25 Billion in 2024 to USD 26.15 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.5% during the forecast period (2024 - 2032). Technological advancements in surgical robots, a rising preference for minimally invasive surgeries, and an increase in funding for surgical robot research are driving market growth.
By providing exceedingly fine manipulation of surgical tools within constrained operating rooms and outperforming human capabilities, surgical robots offer substantial benefits in minimally invasive surgery. Robotic surgery is a method that falls within the minimally invasive category and represents a change in how many different professions perform. Additionally, minimally invasive operations made possible by surgical robotics include smaller incisions, less damage to the tissues around them, and faster recovery times, all of which contribute to the market's growth. Surgical robots meet the growing demand from patients for procedures that cause less pain and need shorter hospital stays, which helps the market expand. Surgical robotics technology enables surgeons to conduct challenging operations through small incisions, reducing patient trauma, speeding up recovery, and improving patient outcomes.
The primary drivers of the market are the global lack of doctors and surgeons and the growing use of automated surgical tools. The market expansion is also positively impacted by the rising investments made by regional and international companies in developing new, cutting-edge surgical robots. Additionally, the rising incidence of osteoporosis and arthritis cases and the rising demand for hip and knee replacement procedures are key drivers predicted to propel the market's expansion. Additionally, cutting-edge visualization technologies for surgical robots offer surgeons a better view of the operating room and use HD cameras to show tiny structures.
Additionally, the market is being supported by increased use of assisted surgeries such as hysterectomies, increased robotic surgical systems, and ongoing manufacturer R&D efforts related to automated robotic systems. Technology advancements in the area of automated medical instruments, such as the incorporation of sensors, cameras, computing technology, remote navigation technology systems, automated controlled catheters, and various other accessories used for surgical procedures, are also boosting the adoption of automated instruments, which is projected to drive the market over the forecast years.
This week, 2024 saw the record number of Versius surgical robot installations by CMR Surgical Ltd. at the end of 2023. CMR Surgical, a company founded in 2014, reported that at year's end, the number of Versius installations worldwide was more than 50% greater than in 2022. The surgical robot was used in over 17,000 treatments, according to the Cambridge, United Kingdom-based company, marking a growth of more than 60% in just one year. Versius is a compact surgical robot with bedside units for direct patient access and collaborative arms. According to a release from CMR Surgical, it also offers port placement options to better meet the needs of individual patients.
2023: U.S. Food and Drug Administration (FDA) 510(k) clearance for TMINITM Miniature Robotic System was obtained by THINK Surgical, Inc., a pioneer in the field of orthopedic surgical robotics. A wireless robotic handpiece is part of the TMINI system, which helps surgeons do complete knee replacements. The TMINI robotic handpiece locates bone pins in precisely defined planes by automatically compensating for the surgeon's hand movement in accordance with a three-dimensional surgical plan based on CT data.
Johnson & Johnson, a major player in the healthcare industry, continued to shift its focus from COVID-19 to areas like robotic surgery in the first quarter of this year as it prepared to split off its consumer health division later into the consumer-focused company Kenvue. First-quarter earnings are being overshadowed by the talc litigation and settlement.
In August 2023, Stryker introduced a direct patient marketing campaign to improve patient engagement and education. Joint replacement procedures will be the focus of this campaign, which is intended for patients directly rather than doctors. The overall goal is to increase patients’ knowledge about their bodies & health system so that they can make wise decisions concerning their healthcare as well as enhancing their experiences and results.
In July 2022, Medical Microinstruments S.p.A. raised $75m for advancing microsurgery robotics. RA Capital Management and Biostar Capital led the round, while Andera Partners, Fountain Healthcare Partners, Panakès Partners, Sambatech also participated, along with Deerfield Management (who led the round) and other existing investors. Additionally, three new members have been appointed to its board of directors.
In June 2022, Intuitive Surgical Inc., Siemens Healthineers AG, provides improved scanning integration for Ion Endoluminal procedures.
On February 16th, 2022, DePuy Synthes (Orthopaedics Company), a subsidiary of Johnson & Johnson, received approval from the Israeli Ministry of Health (AMAR) on behalf of its Division of Medical Devices towards commercializing VELYSTM Robotic-Assisted Solution in Israel.
The Food and Drug Administration approved Quantum Surgical’s Epionerobot designed for cancer treatment on March 17th, 2022, through FDA’s evaluation regulations for class II premarket approvals (PMA).
On September 1st, 2022, Zimmer Biomet Holdings, Inc. got FDA clearance for the Identity Shoulder System that will be used in shoulder replacement surgeries.
Surgical Robots Market Trends
- Technological Advancements in Surgical Robots to boost the market growth
The demand for minimally invasive surgeries (MIS) is rising globally due to the benefits associated with these treatments, such as smaller incisions, fewer cuts, decreased scarring, reduced discomfort, increased safety, quicker recovery times, and significant cost savings. Robotic minimally invasive surgery, which offers improved accuracy, repeatability, control, and efficiency, enhances these advantages. Furthermore, highly advanced visualization technologies for robotic surgery provide surgeons with a superior perspective of the operating area and utilize HD cameras to display minute structures.
Furthermore, AI Robots can help surgeons access difficult-to-reach areas because they are more agile and have greater dexterity than the human hand. They might move in any direction. advantages of surgical robots and the growing need for better, faster. The benefits of surgical robots and the growing demand for better, quicker healthcare services are anticipated to fuel the market's expansion.
According to the estimate of the market for surgical robots, the interventional category is expected to dominate the market in the next years, as shown in the graph below. The industry is being propelled by the rapid rise in experiments to create novel medications for various ailments as well as laboratory digitalization. According to data from ClinicalTrials.gov, 331,906 (or 77%) of the 429,205 clinical trials were interventional studies. The same data showed that 853 trails were documented due to better access, whereas observational studies made up 95,613 (22% of total research).
Figure 1: Surgical Robots Market Product Type
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Surgical Robots Market Segment Insights
Surgical Robots Product Type Insights
The market segments of surgical robots, based on product type, includes instrument & accessories, robotic systems, and services. The instrument & accessories segment is expected to hold the majority share in 2021 in the surgical robots market revenue. This is due to the adoption of new instruments and accessories with advanced technology. For instance, initiatives surgical has launched da vinci surgical system with interactive robotic arms and endo wrist instruments utilized during surgery.
May 2018:Intuitive Surgical Inc., (US) received FDA clearance in the United States for da Vinci X Surgical System. The da Vinci X System will offer urologic surgical procedures for a single-port approach.
Surgical Robots Application Insights
The surgical robots market segmentation is based on the application that includes gynecologic surgery, general surgery, cardiac surgery, urologic surgery, colorectal surgery, and head and neck surgery. The gynecologic surgery segment is projected to hold the dominant share of the surgical market during the forecast period 2022-2030. This is due to the technological advancement in gynecologic surgery enables surgeons to perform less invasive gynecological surgeries. In addition, gynecologic surgery is expected to expand over the course of the forecasted period as a result of hospitals and other healthcare facilities having more purchasing power.
Surgical Robots Control Mechanism Insights
The surgical robots market data has been bifurcated into direct telemanipulator and computer control. the direct telemanipulator segment accounted to hold the largest share of the market and is projected to be the faster-growing segment during the forecast period, 2022-2030. The growth of the direct telemanipulator segment in the market is mainly due to the increase the possibility for remote surgery and increase the accuracy in the surgery. Teleoperated robotic systems expand human capabilities beyond what is physically and naturally achievable. Therefore, they can be used to do minimally invasive surgery on a patient inside of their body. Furthermore, Over the past few decades, medical robots have become increasingly common as helpful tools for surgical applications, particularly in laparoscopic surgery. The da Vinci telemanipulator (Intuitive Surgical, Sunnyvale, USA) is the industry leader in surgical disciplines as diverse as urology, gynecology, and general surgery. Several smaller, more specialized systems have been proposed for specific applications, primarily focusing on camera guidance in laparoscopic surgery, as opposed to the da Vinci, which integrates multiple robotic arms into an overall system to perform an entire operation via robotic telemanipulation.
January 2018:3D Systems and Stryker had a distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for the craniomaxillofacial specialty. This partnership will drive the availability of personalized surgical planning and techniques to healthcare professionals, saving both surgeons and patients hours in the operating room.
Figure 2: Surgical Robots Market, By Control Mechanism, 2021 & 2030 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Surgical Robots Product End User Insights
The market segmentation of surgical robots, based on End Users, includes Hospitals and Ambulatory Surgical Centers. The Hospitals segment is expected to hold the majority share in 2021 in the market revenue of surgical robots. This is due to the growing healthcare expenditures in various economies. Moreover, hospitals are equipped with advanced surgical robots to improve the quality of care and patient outcomes. According to an NCBI study, 23 of 73 hospitals have performed robotic-assisted surgery, which is expected to rise. Therefore, the rising number of inpatient visits and the increasing number of surgical procedures drove the market growth in this segment.
News:
In addition to its earlier $46 million Series C financing round, Virtual Incision added a $30 million extension. The manufacturer of surgical robots, based in Lincoln, Nebraska, disclosed the initial $46 million financing in November 2021. The limitations of conventional robotic-assisted mainframe machines were considered when Virtual Incision created the MIRA surgical system. It streamlined and downsized the soft tissue robotics technology to increase adoption and accessibility. The $30 million extension will be used by the business to maintain operations "well into 2025" and support its miniature surgical robot. This "miniRAS" technology aims to provide the functionality of conventional surgical robots in a package that can fit inside a surgical tray. Due to MIRA's small size, more patients could benefit from robot-assisted surgery.
Surgical Robots Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America surgical robots market is attributed to the hospitals' increasing financial ability to invest in robotic systems, planned partnerships with other companies, increasing patient acceptance for the use of surgical robots in medical practices leading to better healthcare outcomes, and an increased general understanding of computer-assisted surgeries. Furthermore, it is projected that the prevalence of cardiovascular illness will boost demand for minimally invasive procedures, which will therefore increase demand for robotic surgical systems in the region.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: SURGICAL ROBOTS MARKET SHARE BY REGION 2021 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe surgical robots market is expected to account for the second-largest market share due to the rising surgical procedures in Europe due to the increasing geriatric population. Further, the Germany market of surgical robots is expected to hold 3rd place for the market share, and the UK market of surgical robots is expected to fastest-growing market, and which is in the 4th place in the European region. Furthermore, France market of surgical robots will hold the 5th place for the market share.
The Asia-Pacific surgical robots market is expected to grow at a steady pace from 2024 to 2032. This is due to the increasing prevalence of chronic diseases, the rising geriatric population, new product development, and the growing presence of international players in the region. Moreover, China market of surgical robots is expected to hold the largest market share, and the India market of surgical robots is expected fastest-growing market in the Asia-Pacific region.
For instance, India is rapidly expanding in terms of healthcare R&D, but Japan has a robust research infrastructure and is home to significant pharmaceutical corporations. Chinese manufacturers of surgical robots have advantages over their counterparts elsewhere. They offer more reasonably priced services, such as accessory replacements, training, and maintenance, which increases their market competitiveness in addition to having a better grasp of Chinese doctors and patients, making it to be the world leader in the market for surgical robots.
The Rest of the World includes the Middle East, Africa, and Latin America. Increasing incidences of chronic diseases, gynecological diseases, orthopedic diseases, urological diseases, neurological diseases, cardiothoracic diseases, etc. The adoption of Robotic telesurgery is increasing owing to the rising incidences of cholecystectomy, which is creating growth opportunities in the region and contributing to the market growth of the surgical robots.
Surgical Robots Key Market Players & Competitive Insights
The presence of major market players in the surgical robots market is characterized by the presence of many international, regional, and local players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Merck Co. & Inc, Verb Surgical Inc, Smith & Nephew, Renishaw, and Stryker Corporation dominate the Surgical Robots market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the primary business strategies adopted by manufacturers in the surgical robots industry to benefit clients and expand the surgical robots market sector is to manufacture locally to reduce operating costs.
This week, 2024 saw the record number of Versius surgical robot installations by CMR Surgical Ltd. at the end of 2023. CMR Surgical, a company founded in 2014, reported that at year's end, the number of Versius installations worldwide was more than 50% greater than in 2022. The surgical robot was used in over 17,000 treatments, according to the Cambridge, United Kingdom-based company, marking a growth of more than 60% in just one year. Versius is a compact surgical robot with bedside units for direct patient access and collaborative arms. According to a release from CMR Surgical, it also offers port placement options to better meet the needs of individual patients.
2023: U.S. Food and Drug Administration (FDA) 510(k) clearance for TMINITM Miniature Robotic System was obtained by THINK Surgical, Inc., a pioneer in the field of orthopedic surgical robotics. A wireless robotic handpiece is part of the TMINI system, which helps surgeons do complete knee replacements. The TMINI robotic handpiece locates bone pins in precisely defined planes by automatically compensating for the surgeon's hand movement in accordance with a three-dimensional surgical plan based on CT data.
Johnson & Johnson, a major player in the healthcare industry, continued to shift its focus from COVID-19 to areas like robotic surgery in the first quarter of this year as it prepared to split off its consumer health division later into the consumer-focused company Kenvue. First-quarter earnings are being overshadowed by the talc litigation and settlement.
Intuitive Surgical, Inc. is a technology leader in minimally invasive surgery and the pioneer of robot-assisted surgery. The company is helping to solve hard problems in healthcare by working with physicians and hospitals around the globe. Its da Vinci surgical system delivers a less invasive approach to many types of surgery and over 8.5 million procedures were performed worldwide through 2020 using da Vinci systems. The company has more than 25 years of industry experience. The company sells its epilepsy surgery products through the Systems business segment. For instance, in In July 2019, Intuitive Surgical, Inc. (US) acquired SCHÖLLY FIBEROPTIC GMBH (Germany) robotic endoscope business. The strategic acquisition helped the company to expand its product line and manufacturing sites.
Also, Stryker is engaged in developing, manufacturing, and marketing specialty surgical and medical products. The company's products include implants, biologics, surgical, neurologic, ear, and throat and interventional pain equipment, endoscopic, surgical navigation, communications, and digital imaging systems, along with patient handling and emergency medical equipment. It has classified its products into 3 major categories medical & surgical equipment, orthopedics, and neurotechnology. Stryker has 7,784 patents globally till 2018. The company is also listed on the New York Stock Exchange.it was also one of the Fortune 500 companies in 2018.
Key Companies in the market of Surgical Robots includes
- Intuitive Surgical, Inc. (US)
- Mazor Robotics (Israel)
- Hansen Medical (US)
- TransEnterix, Inc. (US)
- Medtech SA (France)
- Verb Surgical Inc (US)
- Smith & Nephew (UK)
- Stryker (US)
- Renishaw PLC (UK)
- Medrobotics Corporation (US)
Surgical Robots Industry Developments
February 2020:Intuitive Surgical, Inc. (US) acquired Orpheus Medical (Israel) to expand its hospital informatics platform. Owing to this acquisition, present, and future clients will have quicker and simpler access to their data.
January 2021:Smith & Nephew (UK) announced the acquisition of the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation. This acquisition will significantly strengthen Smith Nephew’s extremities business by adding a combination of a focused sales channel, complementary shoulder replacement and upper and lower extremities portfolio, and an exciting new product pipeline.
September 2022:Stryker (US) launched Q Guidance System with Spine Guidance Software to receive clearance from the FDA for use with pediatric patients aged 13 and older.
Surgical Robots Market Segmentation
Surgical Robots Product Type Outlook
- Instrument & Accessories
- Robotic Systems
- Services
Surgical Robots Application Outlook
- Gynecologic Surgery
- General Surgery
- Cardiac Surgery
- Urologic Surgery
- Colorectal Surgery
- Head And Neck Surgery
Surgical Robots Control Mechanism Outlook
- Direct Telemanipulator
- Computer Control
Surgical Robots End User Outlook
- Hospitals
- Ambulatory Surgical Centers
Surgical Robots Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
